Advertisement
Screener

Synergy CHC Corp. (SNYR) Foreign Currency Transaction Gain (Loss), Realized

2.8 / 5 stars · 68/120 Roast Me

Synergy CHC Corp. Foreign Currency Transaction Gain (Loss), Realized

Synergy CHC Corp. (SNYR) reported Foreign Currency Transaction Gain (Loss), Realized of $278.13 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-06-29.

Discontinued › Cash Flow › Operating Activities

us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2020-06-29

  • Synergy CHC Corp. foreign currency transaction gain (loss), realized for the quarter ending 2020-03-31 was $278.13K.
  • Synergy CHC Corp. foreign currency transaction gain (loss), realized for the quarter ending 2019-12-31 was $104.27K, a 305.16% increase year-over-year.
  • Synergy CHC Corp. foreign currency transaction gain (loss), realized for the quarter ending 2019-09-30 was -$101.29K.
  • Synergy CHC Corp. foreign currency transaction gain (loss), realized for the quarter ending 2019-06-30 was $27.77K, a 76.98% decline year-over-year.
  • Synergy CHC Corp. foreign currency transaction gain (loss), realized for fiscal 2019 was -$8.28K.
  • Synergy CHC Corp. foreign currency transaction gain (loss), realized for fiscal 2018 was -$171.94K.
Period endForeign Currency Transaction Gain (Loss), Realized 3 monthForeign Currency Transaction Gain (Loss), Realized 6 monthForeign Currency Transaction Gain (Loss), Realized 9 monthForeign Currency Transaction Gain (Loss), Realized 12 month
2020-03-31$278.13K
10-Q · filed 2020-06-29
$382.40K
derived: sum of 2 quarters · filed 2020-06-29
$281.11K
derived: sum of 3 quarters · filed 2020-06-29
$308.88K
derived: sum of 4 quarters · filed 2020-06-29
2019-12-31$104.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29
$2.98K
derived: sum of 2 quarters · filed 2020-04-29
$30.75K
derived: sum of 3 quarters · filed 2020-04-29
-$8.28K
10-K · filed 2020-04-29
2019-09-30-$101.29K
10-Q · filed 2019-11-14
-$73.52K
derived: sum of 2 quarters · filed 2019-11-14
-$112.55K
10-Q · filed 2019-11-14
-$64.29K
derived: sum of 4 quarters · filed 2020-06-29
2019-06-30$27.77K
10-Q · filed 2019-08-13
-$11.26K
10-Q · filed 2019-08-13
$37.00K
derived: sum of 3 quarters · filed 2020-06-29
-$29.36K
derived: sum of 4 quarters · filed 2020-06-29
2019-03-31-$16.51K
10-Q · filed 2020-06-29
$9.23K
derived: sum of 2 quarters · filed 2020-06-29
-$57.13K
derived: sum of 3 quarters · filed 2020-06-29
$63.50K
derived: sum of 4 quarters · filed 2020-06-29
2018-12-31$25.74K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29
-$40.62K
derived: sum of 2 quarters · filed 2020-04-29
$80.01K
derived: sum of 3 quarters · filed 2020-04-29
-$171.94K
10-K · filed 2020-04-29
2018-09-30-$66.35K
10-Q · filed 2019-11-14
$54.27K
derived: sum of 2 quarters · filed 2019-11-14
-$197.67K
10-Q · filed 2019-11-14
2018-06-30$120.62K
10-Q · filed 2019-08-13
-$131.32K
10-Q · filed 2019-08-13
2018-03-31$10.70K
10-Q · filed 2019-05-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Functional Brands Inc. (MEHA)United States$0.001B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
MANNATECH INC (MTEX)United States$0.014B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87